More Post from the Author
- Helser Brothers to Showcase the One-of-a-Kind Motorized French Pole at CWC 2025
- ProCap BTC Announces Executive Team and Appreciation of its Bitcoin Holdings by More Than $60 Million in Less Than 90 Days
- One Park Financial Earns Great Place to Work Certification for the Eighth Time
- DRUID AI sammelt 31 Millionen Dollar in Serie C ein, um das Wachstum der Agentic-KI-Plattform unter dem neuen Geschftsfhrer Joseph Kim zu beschleunigen
- G-P Named an Industry Leader in NelsonHall's Global Employer of Record (EOR) Market Analysis for Fifth Consecutive Report
AdventHealth Tampa is first in Tampa Bay to offer implantable chemotherapy pump for patients with metastatic colorectal cancer
Published on Wed 19 Mar 2025 9:40:06 UTC

Hepatic Artery Infusion therapy delivers treatment directly tometastatic tumors in the liver, while minimizing the potential for systemic side effects
TAMPA, Fla., March 18, 2025 /PRNewswire/ -- AdventHealth Tampa is the first in the Tampa Bay area to offer a powerful new pump-based treatment option for colorectal cancer that has spread to the liver and for a rare form of cancer that forms in bile ducts within the liver called intrahepatic cholangiocarcinoma.
Hepatic Artery Infusion (HAI) therapy uses a pump that is implanted just below the skin in a patient's abdominal wall to deliver medicine directly to the liver through the hepatic artery, maximizing drug delivery to the tumors without adding systemic side effects.
More Post from the Author
- Helser Brothers to Showcase the One-of-a-Kind Motorized French Pole at CWC 2025
- ProCap BTC Announces Executive Team and Appreciation of its Bitcoin Holdings by More Than $60 Million in Less Than 90 Days
- One Park Financial Earns Great Place to Work Certification for the Eighth Time
- DRUID AI sammelt 31 Millionen Dollar in Serie C ein, um das Wachstum der Agentic-KI-Plattform unter dem neuen Geschftsfhrer Joseph Kim zu beschleunigen
- G-P Named an Industry Leader in NelsonHall's Global Employer of Record (EOR) Market Analysis for Fifth Consecutive Report